PTC Therapeutics Inc.

NASDAQ: PTCT · Real-Time Price · USD
48.82
0.12 (0.25%)
At close: Aug 15, 2025, 3:59 PM
48.92
0.20%
After-hours: Aug 15, 2025, 07:52 PM EDT

PTC Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-64.85M 866.56M -65.89M -106.65M -99.18M -91.58M -155.79M -132.97M -198.88M -138.96M -170.89M -109.31M -152.09M -126.73M -143.26M -133.62M -118.37M -128.64M
Depreciation & Amortization
7.58M 7.22M 6.76M 6.49M 7.02M 55.4M 80.7M 62.05M 51.01M 42.83M 38.87M 34.48M 29.18M 26.31M 18.81M 16.75M 14.99M 13.59M
Stock-Based Compensation
18.54M 18.06M 17.24M 19.75M 19.24M 18.38M 16.51M 56.51M 29.37M 28.82M 27.34M 28.67M 27.73M 26.59M 26.24M 25.87M 25.7M 25.71M
Other Working Capital
-27.84M 8.2M -15.27M -48.48M -17.43M 104.89M -96.87M 3.7M -214K 53.23M 8.51M -51.56M 20.45M 21.52M -34.47M 30K -1.93M 11.67M
Other Non-Cash Items
-2.89M 15.65M 31.21M 57.76M 12.64M 23.05M 36.92M -7.62M 122.9M -883K -40.2M 45.08M 30.04M 13.6M 34.85M 27.15M 17.19M 17.59M
Deferred Income Tax
-2K 2K -55.91M -3K 2K -1K 3.98M -2K -50.9M -4K n/a n/a n/a n/a 377K 22.05M -2.23M 11.73M
Change in Working Capital
-16.72M -37.4M 36.58M -54.33M -11.18M 65.51M -82.61M 7.51M 32.39M 38.72M -21.09M -36.96M 9.89M -37.18M -5.85M -9.39M 31.59M -40.13M
Operating Cash Flow
-58.33M 870.1M -30M -76.99M -71.45M 70.76M -100.29M -14.52M -14.12M -29.49M -165.96M -38.05M -55.24M -97.4M -68.84M -51.19M -31.14M -100.16M
Capital Expenditures
-509K -2.53M -6.5M 54.24M 7.38M -64.35M -28.46M -29.21M -19.28M -43.67M -27M -26.02M -17.99M -81.45M -24.04M -25.81M -15.62M -19.86M
Cash Acquisitions
n/a n/a n/a -28.04M 28.04M n/a -35.89M 22.85M 13.04M n/a n/a -141.83M -80.95M 78.61M -1.67M 19.97M 7.65M 14.19M
Purchase of Investments
-538.19M -327.54M -141.07M -219.08M -195.7M -113.44M -186.11M -8.22M -18.16M -2.17M -12.34M -22.79M -1.39M -39.03M -61.41M -88.83M -50.95M -342.08M
Sales Maturities Of Investments
118.63M 145.65M 265.28M 175.24M 94.37M 62.86M 120.15M 7.83M 13.69M 14.7M 71.77M 185.26M 91.64M 169.52M 153.72M 179.34M 122.62M 392.09M
Other Investing Acitivies
-1.14M -738K 147.27M -25.04M n/a n/a 35.89M -22.85M -13.04M 2.17M -18.38M 141.83M 80.95M -78.61M 1.67M -19.97M -7.65M -14.19M
Investing Cash Flow
-422.01M -184.36M 267.71M -42.67M -65.92M -114.93M -94.42M -29.6M -23.75M -28.97M 32.44M 136.44M 72.25M 49.04M 68.27M 64.7M 56.06M 30.15M
Debt Repayment
n/a n/a 1.49M n/a n/a -1.49M -381.65M 1.29M n/a -1.56M 300M -150M n/a -1.28M n/a n/a n/a -2.22M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.96M -6.34M -1.49M -18.2M 241.79M n/a 999.72M -1.38M 18.46M 5.66M 2.92M 10.01M 3.86M 2.44M 4.35M 2.98M 4.02M 11.76M
Financial Cash Flow
3.96M 9.41M 26.47M -17.63M 246.48M 540K 620.49M 3.36M 18.46M 4.09M 302.92M -140M 3.86M 1.17M 4.35M 2.98M 4.02M 9.53M
Net Cash Flow
-462.79M 700.55M 255.53M -128.75M 103.92M -45.65M 428.84M -43.09M -9.1M -62.33M 175.41M -53.73M 22.57M -45.54M -100K 12.47M 30.71M -62.18M
Free Cash Flow
-58.84M 867.57M -36.5M -22.75M -64.08M 6.41M -128.75M -43.73M -33.4M -73.16M -192.96M -64.07M -73.23M -178.85M -92.88M -77M -46.77M -120.02M